{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:17:02Z","timestamp":1774653422408,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-022-02393-8","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T22:02:50Z","timestamp":1661378570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Fabrication of TPGS-Grafted Polyamidoamine Dendrimer for Enhanced Piperine Brain Delivery and Pharmacokinetics"],"prefix":"10.1208","volume":"23","author":[{"given":"Ajit","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshada","family":"Mhaske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4864-0133","authenticated-orcid":false,"given":"Rahul","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"key":"2393_CR1","first-page":"521","volume":"7","author":"D Brambilla","year":"2011","unstructured":"Brambilla D, le Droumaguet B, Nicolas J, Hashemi SH, Wu LP, Moghimi SM, et al. Nanotechnologies for Alzheimer\u2019s disease: diagnosis, therapy, and safety issues. Nanomedicine: Nanotechnology. Biol Med Elsevier. 2011;7:521\u201340.","journal-title":"Biol Med. Elsevier"},{"key":"2393_CR2","unstructured":"Casey DA, Antimisiaris D, O\u2019Brien J. Drugs for Alzheimer\u2019s disease: are they effective? Pharmacy and Therapeutics. 2010;35:208\u201311."},{"key":"2393_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"W Henry","year":"2010","unstructured":"Henry W, Querfurth HW, LaFerla FM. Mechanisms of disease Alzheimer\u2019s disease. New Engl J Med. 2010;362:329\u201344.","journal-title":"New Engl J Med"},{"key":"2393_CR4","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.fct.2009.12.009","volume":"48","author":"P Chonpathompikunlert","year":"2010","unstructured":"Chonpathompikunlert P, Wattanathorn J, Muchimapura S. Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer\u2019s disease. Food Chem Toxicol Pergamon. 2010;48:798\u2013802.","journal-title":"Food Chem Toxicol Pergamon"},{"key":"2393_CR5","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1002\/jps.24557","volume":"104","author":"YSR Elnaggar","year":"2015","unstructured":"Elnaggar YSR, Etman SM, Abdelmonsif DA, Abdallah OY. Intranasal piperine-loaded chitosan nanoparticles as brain-targeted therapy in Alzheimer\u2019s disease: optimization, biological efficacy, and potential toxicity. J Pharm Sci Elsevier. 2015;104:3544\u201356.","journal-title":"J Pharm Sci Elsevier"},{"key":"2393_CR6","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1208\/s12249-018-1180-3","volume":"19","author":"SM Etman","year":"2018","unstructured":"Etman SM, Elnaggar YSR, Abdelmonsif DA, Abdallah OY. Oral brain-targeted microemulsion for enhanced piperine delivery in Alzheimer\u2019s disease therapy: in vitro appraisal, in vivo activity, and nanotoxicity. AAPS PharmSciTech. 2018;19:3698\u2013711.","journal-title":"AAPS PharmSciTech"},{"key":"2393_CR7","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1016\/j.drudis.2021.07.020","volume":"26","author":"M Handa","year":"2021","unstructured":"Handa M, Tiwari S, Yadav AK, Almalki WH, Alghamdi S, Alharbi KS, et al. Therapeutic potential of nanoemulsions as feasible wagons for targeting Alzheimer\u2019s disease. Drug Discov Today Elsevier Current Trends. 2021;26:2881\u20138.","journal-title":"Drug Discov Today Elsevier Current Trends"},{"key":"2393_CR8","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.drudis.2021.04.011","volume":"26","author":"R Shukla","year":"2021","unstructured":"Shukla R, Singh A, Handa M, Flora SJS, Kesharwani P. Nanotechnological approaches for targeting amyloid-\u03b2 aggregation with potential for neurodegenerative disease therapy and diagnosis. Drug Discov Today Elsevier Current Trends. 2021;26:1972\u20139.","journal-title":"Drug Discov Today Elsevier Current Trends"},{"key":"2393_CR9","doi-asserted-by":"crossref","unstructured":"Nowacek A, Gendelman HE. NanoART, neuroAIDS and CNS drug delivery. Future Medicine Ltd London, UK. 2009;4:557\u201374. Available from: https:\/\/www.futuremedicine.com\/doi\/abs\/10.2217\/nnm.09.38","DOI":"10.2217\/nnm.09.38"},{"key":"2393_CR10","doi-asserted-by":"crossref","unstructured":"Ray E, Vaghasiya K, Sharma A, Shukla R, Khan R, Kumar A, Verma RK.\u00a0Autophagy-inducing inhalable co-crystal formulation of niclosamide-nicotinamide for lung cancer therapy. AAPS PharmSciTech. 2020;21:1\u201314. Available from: https:\/\/link.springer.com\/article\/10.1208\/s12249-020-01803-z","DOI":"10.1208\/s12249-020-01803-z"},{"key":"2393_CR11","doi-asserted-by":"crossref","unstructured":"Khairnar P, Handa M, Shukla R. Nanocrystals: an approachable delivery system for anticancer therapeutics. Current Drug Metabolism Bentham Science Publishers Ltd. 2022;23.","DOI":"10.2174\/1389200223666220610165850"},{"key":"2393_CR12","doi-asserted-by":"crossref","unstructured":"Mule S, Khairnar P, Shukla R. Recent advances in nanocrystals heralding greater potential in brain delivery. Particle & Particle Systems Characterization John Wiley & Sons, Ltd. 2022;2200087. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/ppsc.202200087","DOI":"10.1002\/ppsc.202200087"},{"key":"2393_CR13","doi-asserted-by":"crossref","unstructured":"Xu L, Zhang H, Wu Y. Dendrimer advances for the central nervous system delivery of therapeutics.\u00a0ACS Chem Neurosci. 2014;5:2\u201313. Available from: https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/cn400182z","DOI":"10.1021\/cn400182z"},{"key":"2393_CR14","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.addr.2005.09.019","volume":"57","author":"R Duncan","year":"2005","unstructured":"Duncan R, Izzo L. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev Elsevier. 2005;57:2215\u201337.","journal-title":"Adv Drug Deliv Rev Elsevier"},{"key":"2393_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jconrel.2018.10.006","volume":"291","author":"SD Santos","year":"2018","unstructured":"Santos SD, Xavier M, Leite DM, Moreira DA, Cust\u00f3dio B, Torrado M, et al. PAMAM dendrimers: blood-brain barrier transport and neuronal uptake after focal brain ischemia. J Control Release Elsevier. 2018;291:65\u201379.","journal-title":"J Control Release Elsevier"},{"key":"2393_CR16","doi-asserted-by":"crossref","unstructured":"Guo Y, Chu M, Tan S, Zhao S, Liu H, Otieno BO, Yang X, Xu C, Zhang Z.\u00a0Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.\u00a0Mol Pharm. 2014;11:59\u201370. Available from: https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/mp400514t","DOI":"10.1021\/mp400514t"},{"key":"2393_CR17","doi-asserted-by":"crossref","unstructured":"Singh A, Ujjwal RR, Naqvi S, Verma RK, Tiwari S, Kesharwani P, Shukla R. Formulation development of tocopherol polyethylene glycol nanoengineered polyamidoamine dendrimer for neuroprotection and treatment of Alzheimer disease.\u00a0J Drug Target. 2022;7:1\u201352. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/1061186X20222063297","DOI":"10.1080\/1061186X.2022.2063297"},{"key":"2393_CR18","doi-asserted-by":"crossref","unstructured":"\u00d6rberg ML, Schill\u00e9n K, Nylander T. Dynamic light scattering and fluorescence study of the interaction between double-stranded DNA and poly(amido amine) dendrimers. Biomacromolecules. 2007;8:1557\u201363. Available from: https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/bm061194z","DOI":"10.1021\/bm061194z"},{"key":"2393_CR19","doi-asserted-by":"crossref","unstructured":"Tawfik MA, Tadros MI, Mohamed MI. Polyamidoamine (PAMAM) dendrimers as potential release modulators and oral bioavailability enhancers of vardenafil hydrochloride.\u00a0Pharm Dev Technol.\u00a02018;24:293\u2013302. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/10837450.2018.1472611","DOI":"10.1080\/10837450.2018.1472611"},{"key":"2393_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.colsurfb.2014.06.059","volume":"121","author":"D Pooja","year":"2014","unstructured":"Pooja D, Kulhari H, Singh MK, Mukherjee S, Rachamalla SS, Sistla R. Dendrimer\u2013TPGS mixed micelles for enhanced solubility and cellular toxicity of taxanes. Colloids Surf B: Biointerfaces Elsevier. 2014;121:461\u20138.","journal-title":"Colloids Surf B: Biointerfaces Elsevier"},{"key":"2393_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijpharm.2006.03.023","volume":"318","author":"K Gardikis","year":"2006","unstructured":"Gardikis K, Hatziantoniou S, Viras K, Wagner M, Demetzos C. A DSC and Raman spectroscopy study on the effect of PAMAM dendrimer on DPPC model lipid membranes. Int J Pharm Elsevier. 2006;318:118\u201323.","journal-title":"Int J Pharm Elsevier"},{"key":"2393_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.colsurfa.2013.04.003","volume":"431","author":"M Tajabadi","year":"2013","unstructured":"Tajabadi M, Khosroshahi ME, Bonakdar S. An efficient method of SPION synthesis coated with third generation PAMAM dendrimer. . Colloids Surf A: Physicochem Eng Aspects Elsevier. 2013;431:18\u201326.","journal-title":". Colloids Surf A: Physicochem Eng Aspects Elsevier"},{"key":"2393_CR23","doi-asserted-by":"crossref","unstructured":"Jackson CL, Chanzy HD, Booy FP, Drake BJ, Tomalia DA, Bauer BJ, Amis EJ. Visualization of dendrimer molecules by transmission electron microscopy (TEM): staining methods and cryo-TEM of vitrified solutions. Macromolecules.\u00a01998;31:6259\u201365. Available from: https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/ma9806155","DOI":"10.1021\/ma9806155"},{"key":"2393_CR24","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1021\/acschemneuro.9b00343","volume":"10","author":"KV Krishna","year":"2019","unstructured":"Krishna KV, Wadhwa G, Alexander A, Kanojia N, Saha RN, Kukreti R, et al. Design and biological evaluation of lipoprotein-based donepezil nanocarrier for enhanced brain uptake through oral delivery. ACS Chem Neurosci Am Chem Soc. 2019;10:4124\u201335.","journal-title":"ACS Chem Neurosci Am Chem Soc"},{"key":"2393_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0168-3659(03)00200-1","volume":"90","author":"AS Chauhan","year":"2003","unstructured":"Chauhan AS, Sridevi S, Chalasani KB, Jain AK, Jain SK, Jain NK, et al. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. J Control Release Elsevier. 2003;90:335\u201343.","journal-title":"J Control Release Elsevier"},{"key":"2393_CR26","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1016\/j.jchromb.2011.08.018","volume":"879","author":"J Liu","year":"2011","unstructured":"Liu J, Bi Y, Luo R, Wu X. Simultaneous UFLC\u2013ESI\u2013MS\/MS determination of piperine and piperlonguminine in rat plasma after oral administration of alkaloids from Piper longum L.: application to pharmacokinetic studies in rats. J Chromatography B Elsevier. 2011;879:2885\u201390.","journal-title":"J Chromatography B Elsevier"},{"key":"2393_CR27","doi-asserted-by":"crossref","unstructured":"Asthana A, Chauhan AS, Diwan PV, Jain NK. Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site specific delivery of acidic anti-inflammatory active ingredient. AAPS PharmSciTech. 2005;6:536\u201342. Available from: https:\/\/link.springer.com\/article\/10.1208\/pt060367","DOI":"10.1208\/pt060367"},{"key":"2393_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.biomaterials.2010.09.002","volume":"32","author":"H He","year":"2011","unstructured":"He H, Li Y, Jia XR, Du J, Ying X, Lu WL, et al. PEGylated poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors. Biomaterials Elsevier. 2011;32:478\u201387.","journal-title":"Biomaterials Elsevier"},{"key":"2393_CR29","doi-asserted-by":"crossref","unstructured":"Khare V, Sakarchi W al, Gupta PN, Curtis ADM, Hoskins C. Synthesis and characterization of TPGS\u2013gemcitabine prodrug micelles for pancreatic cancer therapy. RSC Advances. 2016;6:60126\u201337. Available from: https:\/\/pubs.rsc.org\/en\/content\/articlehtml\/2016\/ra\/c6ra09347g","DOI":"10.1039\/C6RA09347G"},{"key":"2393_CR30","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.scriptamat.2004.12.026","volume":"52","author":"M Perez","year":"2005","unstructured":"Perez M. Gibbs-Thomson effects in phase transformations. Scripta Materialia Pergamon. 2005;52:709\u201312.","journal-title":"Scripta Materialia Pergamon"},{"key":"2393_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cis.2018.06.005","volume":"257","author":"LJ Fox","year":"2018","unstructured":"Fox LJ, Richardson RM, Briscoe WH. PAMAM dendrimer - cell membrane interactions. Adva Colloid Interface Sci Elsevier. 2018;257:1\u201318.","journal-title":"Adva Colloid Interface Sci Elsevier"},{"key":"2393_CR32","doi-asserted-by":"crossref","unstructured":"Won YW, Yoon SM, Sonn CH, Lee KM, Kim YH. Nano self-assembly of recombinant human gelatin conjugated with \u03b1-tocopheryl succinate for Hsp90 inhibitor, 17-AAG, delivery. ACS Nano.\u00a02011;5:3839\u201348. Available from: https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/nn200173u","DOI":"10.1021\/nn200173u"},{"key":"2393_CR33","doi-asserted-by":"crossref","unstructured":"Chen W, Miao YQ, Fan DJ, Yang SS, Lin X, Meng LK, Tang X. Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. AAPS PharmSciTech.\u00a02011;12:705\u201311. Available from: https:\/\/link.springer.com\/article\/10.1208\/s12249-011-9632-z","DOI":"10.1208\/s12249-011-9632-z"},{"key":"2393_CR34","doi-asserted-by":"crossref","unstructured":"Meng X, Liu J, Yu X, Li J, Lu X, Shen T. Pluronic F127 and D-\u03b1-tocopheryl polyethylene glycol succinate (TPGS) mixed micelles for targeting drug delivery across the blood brain barrier.\u00a0Sci Rep. 2017;7:1\u201312. Available from: https:\/\/www.nature.com\/articles\/s41598-017-03123-y","DOI":"10.1038\/s41598-017-03123-y"},{"key":"2393_CR35","doi-asserted-by":"crossref","unstructured":"Kadam RS, Bourne DWA, Kompella UB. Nano-advantage in enhanced drug delivery with biodegradable nanoparticles: contribution of reduced clearance.\u00a0Drug Metab Dispos. 2012;40:1380\u20138. Available from: https:\/\/dmd.aspetjournals.org\/content\/40\/7\/1380","DOI":"10.1124\/dmd.112.044925"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02393-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-022-02393-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02393-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T16:07:00Z","timestamp":1666714020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-022-02393-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["2393"],"URL":"https:\/\/doi.org\/10.1208\/s12249-022-02393-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]},"assertion":[{"value":"2 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"236"}}